Industry News
DNA timber fingerprinting may assist fight against illegal logging
Advances in DNA 'fingerprinting' and other genetic techniques are making it harder for illegal loggers to get away with destroying protected rainforests.
[ + ]UniQuest brokers international biofuel partnership
The University of Queensland and Clemson University in the US will collaborate on research and development on a range of biofuel technologies. [ + ]
BIO 2011 report: Australian biotechnology trials and tribulations
The last 12 months has been one of tremendous ups and downs for Australian biotechnology companies. [ + ]
Collaboration contributes to understanding toxicity of the new E. coli strain
HPA researchers, using Thermo Scientific's mass spectrometry technology, have been able to identify the protein toxins expressed by the deadly strain of E. coli in Europe.
[ + ]BIO 2011 report: Australian biotechnology spotlight
ALS surveys some of the big movers and shakers in the Australian biotechnology industry from the year that’s past and the year ahead. [ + ]
Starpharma brings its novel technology to leading cancer treatment
Starpharma (ASX:SPL) is conducting pre-clinical studies on popular chemotherapy treatment, docaetaxel, reformulated using the company’s dendrimer technology. [ + ]
BIO 2011: Kim Carr on the importance of biotechnology
Senator Kim Carr, Minister for Innovation, Industry, Science and Research, says biotechnology is central to Labor’s agenda. [ + ]
R&D Tax Credit positions Australian biotechs for Asian boom
The R&D Tax Credit will bring more research funding to Australia to capitalise on the burgeoning Asian health market, says Barry Thomas from Cook Medical. [ + ]
Life Sciences Queensland to officially launch this week
Life Sciences Queensland, a new industry association for the biotechnology sector in the sunshine state, will officially commence operations on 1 July. [ + ]
Australian biotechs front up at BIO 2011
Over 30 Australian life sciences organisations and biotechnology companies will be present at BIO 2011, which launches today. [ + ]
BIO 2011 biotech profile: Patrys, from theory to practice
Taking Patrys’ antibody technology from the lab to the clinic was no small feat. Now those hurdles have been overcome, Patrys is looking towards the future. [ + ]
BIO 2011 biotech profile: Patrys
Patrys has overcome substantial hurdles to show its innovative approach to cancer treatment using natural antibodies is ready for the big leagues. [ + ]
CSL receives official warning from FDA
The US Food and Drug Administration has issued an official warning letter to CSL listing concerns about the manufacture of influenza vaccine, Afluria. [ + ]
AusBiotech supports research exemption in patent reform Bill
AusBiotech has welcomed the research exemption from patent infringement in Australia’s intellectual property reform bill introduced into Parliament today. [ + ]
BIO 2011 biotech profile: Mesoblast’s vision from the top
Mesoblast CEO, Professor Silviu Itescu , was instrumental in cutting the historic billion-dollar deal with Cephalon. He speaks to ALS about how he did it. [ + ]
